These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33227335)

  • 1. Short- and long-term functional results following drug-coated balloons versus drug- eluting stents in small coronary vessels: The RESTORE quantitative flow ratio study.
    Li L; Guan C; Meng S; Bai Y; Zhang Z; Zou K; Ruan Y; Cao X; Jia R; Guo C; Escaned J; Jin Z; Xu B
    Int J Cardiol; 2021 Mar; 327():45-51. PubMed ID: 33227335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial.
    Tang Y; Qiao S; Su X; Chen Y; Jin Z; Chen H; Xu B; Kong X; Pang W; Liu Y; Yu Z; Li X; Li H; Zhao Y; Wang Y; Li W; Tian J; Guan C; Xu B; Gao R;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2381-2392. PubMed ID: 30522667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cut-off values of lesion and vessel quantitative flow ratio in de novo coronary lesion post-drug-coated balloon therapy predicting vessel restenosis at mid-term follow-up.
    Meng PN; Liu B; Li LB; Yin DL; Zhang H; Pan DF; You W; Wu ZM; Wu XQ; Zhao L; Li ZB; Wang JP; Wang ZH; Xu T; Huang XY; Gao RN; Ye F
    Chin Med J (Engl); 2021 Jun; 134(12):1450-1456. PubMed ID: 34091522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implication of quantitative flow ratio to predict clinical events after drug-coated balloon angioplasty in patients with in-stent restenosis.
    Tang J; Hou H; Chu J; Chen F; Yao Y; Gao Y; Ye Z; Zhuang S; Lai Y; Liu X
    Clin Cardiol; 2021 Jul; 44(7):978-986. PubMed ID: 34009672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial.
    Fahrni G; Scheller B; Coslovsky M; Gilgen N; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Zweiker R; Twerenbold R; Kaiser C; Jeger R;
    Clin Res Cardiol; 2020 Sep; 109(9):1114-1124. PubMed ID: 31993736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Sanz Sánchez J; Chiarito M; Cortese B; Moretti A; Pagnotta P; Reimers B; Stefanini GG; Ferrante G
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):66-75. PubMed ID: 32592437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: The RESTORE Small Vessel Disease China trial.
    Tian J; Tang YD; Qiao S; Su X; Chen Y; Jin Z; Chen H; Xu B; Kong X; Pang W; Liu Y; Yu Z; Li X; Li H; Zhao Y; Wang Y; Li W; Guan C; Gao R; Xu B;
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():587-597. PubMed ID: 31943693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial.
    Cortese B; Di Palma G; Guimaraes MG; Piraino D; Orrego PS; Buccheri D; Rivero F; Perotto A; Zambelli G; Alfonso F
    JACC Cardiovasc Interv; 2020 Dec; 13(24):2840-2849. PubMed ID: 33248978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute.
    Yu X; Ji F; Xu F; Zhang W; Wang X; Lu D; Yang C; Wang F
    Clin Res Cardiol; 2019 Mar; 108(3):234-243. PubMed ID: 30074078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Cai X; Tian F; Jing J; Jin Q; Zhou S; Yin W; Chen Y; Wu Q; Fu Z; Chen Y
    Catheter Cardiovasc Interv; 2021 May; 97 Suppl 2():1048-1054. PubMed ID: 33742738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy.
    Asano T; Katagiri Y; Collet C; Tenekecioglu E; Miyazaki Y; Sotomi Y; Amoroso G; Aminian A; Brugaletta S; Vrolix M; Hernandez-Antolín R; van de Harst P; Íñiguez-Romo A; Janssens L; Smits PC; Wykrzykowska JJ; Ribeiro VG; Pereira H; da Silva PC; Piek JJ; Reiber JHC; von Birgelen C; Sabaté M; Onuma Y; Serruys PW
    EuroIntervention; 2018 Aug; 14(5):e570-e579. PubMed ID: 28994655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
    de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
    Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2.
    Gilgen N; Farah A; Scheller B; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Jamshidi P; Leibundgut G; Möbius-Winkler S; Zweiker R; Krackhardt F; Butter C; Bruch L; Kaiser C; Hoffmann A; Rickenbacher P; Mueller C; Stephan FP; Coslovsky M; Jeger R;
    Clin Cardiol; 2018 May; 41(5):569-575. PubMed ID: 29527709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
    Wöhrle J; Scheller B; Seeger J; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger RV;
    JACC Cardiovasc Interv; 2021 Aug; 14(16):1789-1798. PubMed ID: 34412797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.
    Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of quantitative flow ratio after second-generation drug-eluting stent implantation to clinical outcomes.
    Suzuki N; Nishide S; Kimura T; Aoyagi T; Kanamori K; Shiratori Y; Hayami N; Murakawa Y; Kozuma K
    Heart Vessels; 2020 Jun; 35(6):743-749. PubMed ID: 31865431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
    Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.